![](/img/cover-not-exists.png)
Per Pathogen Outcomes from the ZEUS study, a Multi-center, Randomized, Double-Blind Phase 2/3 Study of ZTI-01 (fosfomycin for injection) vs. Piperacillin-Tazobactam (P-T) in the Treatment of Patients with Complicated Urinary Tract Infections (cUTI) including Acute Pyelonephritis (AP)
Skarinsky, David, Eckburg, Paul B, Das, Anita, Manvelian, Kristina, Ellis-Grosse, Evelyn JVolume:
4
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofx163.1363
Date:
October, 2017
File:
PDF, 101 KB
english, 2017